Health Care-Associated Transmission of Hepatitis B and C in Oncology Care

Clinics in Liver Disease

Volumn 14, Issue 1, 2010, Pages 69-74

  Stevens, Michael P ^a   Edmond, Michael B ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Health care associated infections; Hepatitis B; Hepatitis C; Oncology

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

BLOOD TRANSFUSION; CANCER CENTER; CANCER PATIENT; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; HEALTH CARE; HEALTH EDUCATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RISK; ONCOLOGY; OUTPATIENT; REVIEW; RISK REDUCTION; SCREENING; SEROPREVALENCE; UNITED STATES; VACCINATION; VIRUS TRANSMISSION;

AMBULATORY CARE; BLOOD TRANSFUSION; CROSS INFECTION; HEPATITIS B; HEPATITIS C; HUMANS; INFECTION CONTROL; MEDICAL ONCOLOGY; ONCOLOGY SERVICE, HOSPITAL; RISK FACTORS;

EID: 74549194488     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cld.2009.11.006     Document Type: Review

References (28)

1. Styczynski J., Wysocki M., Koltan S., et al. Epidemiologic aspects and preventive strategy of hepatitis B and C viral infections in children with cancer. Pediatr Infect Dis J 20 11 (2001) 1042-1049
2. Locasciulli A., Testa M., Pontisso P., et al. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 90 11 (1997) 4628-4633
3. Locasciulli A., and Alberti A. Hepatitis C virus serum markers and liver disease in children with leukemia. Leuk Lymphoma 17 3-4 (1995) 245-249
4. Hetherington M.L., and Buchanan G.R. Elevated serum transaminase values during therapy for acute lymphoblastic leukemia correlate with prior blood transfusions. Cancer 62 8 (1988) 1614-1618
5. Goldfield M., Black H.C., Bill J., et al. The consequences of administering blood pretested for HBs Ag by third generation techniques: a progress report. Am J Med Sci 270 2 (1975) 335-342
6. Allain J.P., Stramer S.L., Carneiro-Proietti A.B., et al. Transfusion-transmitted infectious diseases. Biologicals 37 2 (2009) 71-77
7. Donahue J.G., Muñoz A., Ness P.M., et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 327 6 (1992) 369-373
8. O'Brien S.F., Yi Q.L., Fan W., et al. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian blood services. Transfusion 47 2 (2007) 316-325
9. Busch M.P., Glynn S.A., Stramer S.L., et al. A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 45 2 (2005) 254-264
10. Shang G., Seed C.R., Wang F., et al. Residual risk of transfusion-transmitted viral infections in Shenzhen, China 2001 through 2004. Transfusion 47 3 (2007) 529-539
11. Chambers L.A., and Popovsky M.A. Decrease in reported posttransfusion hepatitis. Contributions of donor screening for alanine aminotransferase and antibodies to hepatitis B core antigen and changes in the general population. Arch Intern Med 151 12 (1991) 2445-2448
12. Busch M.P. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing. Vox Sang 74 Suppl 2 (1998) 147-154
13. Stramer S.L. Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med 131 5 (2007) 702-707
14. Kebudi R., Ayan I., Yílmaz G., et al. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency virus infections in children with cancer at diagnosis and following therapy in Turkey. Med Pediatr Oncol 34 2 (2000) 102-105
15. Locasciulli A., Nava S., Sparano P., et al. Infections with hepatotropic viruses in children treated with allogeneic bone marrow transplantation. Bone Marrow Transplant 21 Suppl 2 (1998) S75-S77
16. Dodd R.Y., Notari E.P., and Stramer S.L. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 42 8 (2002) 975-979
17. Wasley A., Grytdal S., and Gallagher K. Surveillance for acute viral hepatitis-United States, 2006. MMWR Surveill Summ 57 2 (2008) 1-24
18. Gretch D.R. Diagnostic tests for hepatitis C. Hepatology 26 3 Suppl 1 (1997) 43S-47S
19. Shuhart M.C., Myerson D., Childs B.H., et al. Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course. Blood 84 9 (1994) 3229-3235
20. Silini E., Locasciulli A., Santoleri L., et al. Hepatitis C virus infection in a hematology ward: evidence of nosocomial transmission and impact on hematologic disease outcome. Haematologica 87 11 (2002) 1200-1208
21. Cesaro S., Petris M.G., Rossetti F., et al. Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 90 3 (1997) 1315-1320
22. Widell A., Christensson B., Wiebe T., et al. Epidemiologic and molecular investigation of outbreaks of hepatitis C virus infection on a pediatric oncology service. Ann Intern Med 130 2 (1999) 130-134
23. Allander T., Gruber A., Naghavi M., et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 345 8950 (1995) 603-607
24. Centers for Disease Control and Prevention (CDC). Transmission of hepatitis B and C viruses in outpatient settings-New York, Oklahoma and Nebraska, 2000-2002. MMWR Morb Mortal Wkly Rep 52 38 (2003) 901-906
25. Macedo de Oliveira A., White K.L., Leschinsky D.P., et al. An outbreak of hepatitis C virus infections among outpatients at a hematology/oncology clinic. Ann Intern Med 142 11 (2005) 898-902
26. Centers for Disease Control and Prevention. Injection safety information for providers. Available at:. http://www.cdc.gov/ncidod/dhqp/ps_providerInfo.html Accessed June 17, 2009
27. Wenzel R.P., and Edmond M.B. Patient-to-patient transmission of hepatitis C virus. Ann Intern Med 142 11 (2005) 940-941
28. Thompson N.D., Perz J.F., Moorman A.C., et al. Nonhospital health care-associated hepatitis B and C virus transmission: United States 1998-2008. Ann Intern Med 150 1 (2009) 33-39